Riskpilot← Back to searchSign inGet full accessLI Derm AB
ABActiveOrg 5591117246Vanadisvägen 3Medical specialists activities · NACE 8622Est. 20170 employees
Revenue 2024
SEK 10K
-91% vs 2023
EBITDA margin
1.2%
-100% vs 2023
Equity ratio
49.9%
Financial strength
Net profit 2024
SEK -920
-101% vs 2023
| Revenue | SEK 10K | -91% |
| EBITDA | SEK 121 | -100% |
| Net profit | SEK -920 | -101% |
| Total assets | SEK 98K | -55% |
| Equity | SEK 49K | -57% |
| Employees | 0 | — |
Legal name
LI Derm AB
Org number
5591117246
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
10 maj 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Registrerad särskild delgivningsmottagare saknas. Då minst halva antalet styrelseledamöter och minst halva antalet styrelsesuppleanter ska vara bosatta inom EES uppfyller företaget inte kravet på bosättning.
Company purpose
Bolaget skall bedriva verksamhet inom medicinsk och kirurgisk hudsjukvård samt därmed förenlig verksamhet.
Address
Vanadisvägen 3
Email
lina.ivert@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 26 | 21 | 214 | 113 | 10 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 14 | 12 | 202 | 104 | 0 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 14 | 12 | 202 | 104 | 0 |
| Net financials | — | — | 0 | −0 | −1 |
| Profit before tax | 14 | 87 | 202 | 78 | −1 |
| Tax | −3 | −19 | −42 | −16 | −0 |
| Net profit | 11 | 68 | 160 | 62 | −1 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 147 | 143 | 315 | 220 | 98 |
| Equity | 62 | 130 | 210 | 113 | 49 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 10 | 14 | 105 | 81 | 23 |
| Total debt | 10 | 14 | 105 | 81 | 23 |
EBITDA margin
1.2%
This company
15.8%
Market median
-92% vs market
20202024
Equity ratio
49.9%
This company
38.2%
Market median
+31% vs market
20202024
Return on equity
-1.9%
This company
18.4%
Market median
-110% vs market
20202024
Net profit margin
-8.8%
This company
8.1%
Market median
-209% vs market
20202024
Asset turnover
0.11×
This company
1.12×
Market median
-90% vs market
20202024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LI Derm AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Anders Ivert | Deputy Board Member | 0 companies |
| Lina Ulrika Ivert | Board of Directors | 0 companies |